L.J.B. is listed as an inventor on Issued U.S. Patent 8,080,371, “Markers for Addiction,” which covers the use of certain single nucleotide polymorphisms in determining the diagnosis, prognosis, and treatment of addiction. All other authors reported no biomedical financial interests or potential conflicts of interest. Author disclosures are available in the supporting information.